These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11095272)

  • 1. Implications of trial results: the potentially misleading notions of number needed to treat and average duration of life gained.
    Lubsen J; Hoes A; Grobbee D
    Lancet; 2000 Nov; 356(9243):1757-9. PubMed ID: 11095272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample sizes for clinical trials with time-to-event endpoints and competing risks.
    Schulgen G; Olschewski M; Krane V; Wanner C; Ruf G; Schumacher M
    Contemp Clin Trials; 2005 Jun; 26(3):386-96. PubMed ID: 15911472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the validity of clinical trials.
    Akobeng AK
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):277-82. PubMed ID: 18728521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculating the number needed to treat for trials where the outcome is time to an event.
    Altman DG; Andersen PK
    BMJ; 1999 Dec; 319(7223):1492-5. PubMed ID: 10582940
    [No Abstract]   [Full Text] [Related]  

  • 5. A systematic examination of the citation of prior research in reports of randomized, controlled trials.
    Robinson KA; Goodman SN
    Ann Intern Med; 2011 Jan; 154(1):50-5. PubMed ID: 21200038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection designs for pilot studies based on survival.
    Liu PY; Dahlberg S; Crowley J
    Biometrics; 1993 Jun; 49(2):391-8. PubMed ID: 8369375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Life-years gained from defibrillator implantation: markedly nonlinear increase during 3 years of follow-up and its implications.
    Salukhe TV; Dimopoulos K; Sutton R; Coats AJ; Piepoli M; Francis DP
    Circulation; 2004 Apr; 109(15):1848-53. PubMed ID: 15066946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How should the efficacy of novel treatments be assessed in survival trials?
    Owen A
    Int J Cardiol; 2007 Sep; 120(3):297-300. PubMed ID: 17376549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 12. Exact tests using two correlated binomial variables in contemporary cancer clinical trials.
    Yu J; Kepner JL; Iyer R
    Biom J; 2009 Dec; 51(6):899-914. PubMed ID: 20014199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival analyses of randomized clinical trials adjusted for patients who switch treatments.
    Law MG; Kaldor JM
    Stat Med; 1996 Oct; 15(19):2069-76. PubMed ID: 8896140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size re-estimation for survival data in clinical trials with an adaptive design.
    Togo K; Iwasaki M
    Pharm Stat; 2011; 10(4):325-31. PubMed ID: 22328325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Number needed to treat is incorrect without proper time-related considerations.
    Suissa D; Brassard P; Smiechowski B; Suissa S
    J Clin Epidemiol; 2012 Jan; 65(1):42-6. PubMed ID: 21816576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What's missing from current clinical trial guidelines? A framework for integrating science, ethics, and the community context.
    Sutherland HJ; Meslin EM; Till JE
    J Clin Ethics; 1994; 5(4):297-303. PubMed ID: 7749174
    [No Abstract]   [Full Text] [Related]  

  • 18. What can we learn from clinical trials of anticonvulsant drugs in epilepsy?
    Perucca E
    Eur J Pain; 2002; 6 Suppl A():35-44. PubMed ID: 11888239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case study of the effect of covariate adjustment in a sequential survival clinical trial.
    Todd S; Sahdra M
    J Biopharm Stat; 2001 Nov; 11(4):297-311. PubMed ID: 12018781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.